Determinants of long act reversible contraceptive utilization among HIV positive reproductive age women attending ART clinic in South West Ethiopia.

Bilisumamulifna Tefera Kefeni, Sitota Tesfaye, Kenbon Bayisa, Ebissa Negara, Feyiso Bati
{"title":"Determinants of long act reversible contraceptive utilization among HIV positive reproductive age women attending ART clinic in South West Ethiopia.","authors":"Bilisumamulifna Tefera Kefeni,&nbsp;Sitota Tesfaye,&nbsp;Kenbon Bayisa,&nbsp;Ebissa Negara,&nbsp;Feyiso Bati","doi":"10.1186/s40834-023-00227-x","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Identifying the determinants of long-acting contraceptive utilization and managing the sexual and reproductive health of HIV-infected women is critical to reducing HIV transmission and maternal mortality. However, the determinants of long-acting contraceptive utilization have not been well understood in resource-limited settings like Ethiopia. The aim of this study was to identify determinants of long-acting reversible contraceptive utilization among HIV-positive women on ART in southwest Ethiopia.</p><p><strong>Methods: </strong>A facility-based, unmatched case control study was conducted from July 24 to August 28, 2021, in south-west Ethiopia. The study participants were HIV positive women, with a sample size of 109 cases and controls. An interviewer administered a questionnaire, and a check list was used for data collection. A systemic random sampling technique was used to collect data from cases and controls. Bivariate and multivariable logistic regressions were employed to determine the determinants of LARC utilization among HIV-positive women. To demonstrate the strength of the determinant, the odds ratio was calculated with 95% confidence intervals, and a P-value less than 0.05 was used to declare statistical significance.</p><p><strong>Result: </strong>A total of 324 women (108 cases and 216 controls) of reproductive age who were HIV positive were interviewed, with a response rate of 99.0%. urban residence (AOR = 2.67, 95%CI: 1.23- 5.77), having formal education (AOR = 2.93, 95% CI:1.36, 6.34), being counseled by health care provider (AOR = 5.42,95% CI: 2.67-11.03), no future fertility intention (AOR = 2.87, 95% CI:1.44-5.70), having CD4 count less than 500 cell/mm<sup>3</sup> (AOR = 4.18,95% CI:2.12-8.23), having information of HIV transmission from mother to child (AOR = 3.65,95% CI:1.49-8.95),not using condom during sexual intercourse (AOR = 4.86,95% CI:2.46-9.62),,having knowledge towards LARC (AOR = 2.38,95% CI:1.24-4.58) and attitude towards LARC (AOR = 6.41,95%CI:3.16-13.0) were independent determinants of LARC utilization among HIV positive women.</p><p><strong>Conclusion and recommendation: </strong>Women being counseled by a health care provider, having no future fertility intention, and having a CD4 count less than 500 cells/mm<sup>3</sup> were found to be determinants of long-acting contraceptive method utilization among HIV-positive reproductive-age women. Also, our study supports the WHO Strategic Concepts for Improving the Links between Family Planning and HIV/AIDS Policy, Programs, and Services. It is recommended that Health care providers should use these factors as base line during family planning counseling and service delivery.</p>","PeriodicalId":10637,"journal":{"name":"Contraception and Reproductive Medicine","volume":"8 1","pages":"30"},"PeriodicalIF":0.0000,"publicationDate":"2023-05-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10158019/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Contraception and Reproductive Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1186/s40834-023-00227-x","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Identifying the determinants of long-acting contraceptive utilization and managing the sexual and reproductive health of HIV-infected women is critical to reducing HIV transmission and maternal mortality. However, the determinants of long-acting contraceptive utilization have not been well understood in resource-limited settings like Ethiopia. The aim of this study was to identify determinants of long-acting reversible contraceptive utilization among HIV-positive women on ART in southwest Ethiopia.

Methods: A facility-based, unmatched case control study was conducted from July 24 to August 28, 2021, in south-west Ethiopia. The study participants were HIV positive women, with a sample size of 109 cases and controls. An interviewer administered a questionnaire, and a check list was used for data collection. A systemic random sampling technique was used to collect data from cases and controls. Bivariate and multivariable logistic regressions were employed to determine the determinants of LARC utilization among HIV-positive women. To demonstrate the strength of the determinant, the odds ratio was calculated with 95% confidence intervals, and a P-value less than 0.05 was used to declare statistical significance.

Result: A total of 324 women (108 cases and 216 controls) of reproductive age who were HIV positive were interviewed, with a response rate of 99.0%. urban residence (AOR = 2.67, 95%CI: 1.23- 5.77), having formal education (AOR = 2.93, 95% CI:1.36, 6.34), being counseled by health care provider (AOR = 5.42,95% CI: 2.67-11.03), no future fertility intention (AOR = 2.87, 95% CI:1.44-5.70), having CD4 count less than 500 cell/mm3 (AOR = 4.18,95% CI:2.12-8.23), having information of HIV transmission from mother to child (AOR = 3.65,95% CI:1.49-8.95),not using condom during sexual intercourse (AOR = 4.86,95% CI:2.46-9.62),,having knowledge towards LARC (AOR = 2.38,95% CI:1.24-4.58) and attitude towards LARC (AOR = 6.41,95%CI:3.16-13.0) were independent determinants of LARC utilization among HIV positive women.

Conclusion and recommendation: Women being counseled by a health care provider, having no future fertility intention, and having a CD4 count less than 500 cells/mm3 were found to be determinants of long-acting contraceptive method utilization among HIV-positive reproductive-age women. Also, our study supports the WHO Strategic Concepts for Improving the Links between Family Planning and HIV/AIDS Policy, Programs, and Services. It is recommended that Health care providers should use these factors as base line during family planning counseling and service delivery.

Abstract Image

埃塞俄比亚西南部参加抗逆转录病毒治疗诊所的艾滋病毒阳性育龄妇女使用长效可逆避孕药具的决定因素
背景:确定使用长效避孕药具的决定因素并管理感染艾滋病毒妇女的性健康和生殖健康,对于减少艾滋病毒传播和孕产妇死亡率至关重要。然而,在埃塞俄比亚等资源有限的环境中,长效避孕药具利用的决定因素尚未得到很好的理解。本研究的目的是确定埃塞俄比亚西南部接受抗逆转录病毒治疗的艾滋病毒阳性妇女使用长效可逆避孕药具的决定因素。方法:于2021年7月24日至8月28日在埃塞俄比亚西南部开展了一项基于设施的、无与伦比的病例对照研究。该研究的参与者是艾滋病毒阳性的女性,样本大小为109例和对照组。采访者进行问卷调查,并使用检查表进行数据收集。采用系统随机抽样技术从病例和对照中收集数据。采用双变量和多变量logistic回归来确定hiv阳性妇女使用LARC的决定因素。为了证明决定因素的强度,比值比以95%的置信区间计算,p值小于0.05表示具有统计学显著性。结果:共访谈HIV阳性的育龄妇女324例(108例,216例对照),有效率为99.0%。城市居民(AOR = 2.67, 95%CI: 1.23- 5.77),接受过正规教育(AOR = 2.93, 95%CI: 1.36 - 6.34),接受过卫生保健提供者的咨询(AOR = 5.42,95% CI:2.67 - -11.03),没有未来生育意愿(AOR = 2.87, 95%置信区间CI: 1.44 - -5.70),在细胞CD4计数低于500 / mm3(优势比= 4.18,95% CI: 2.12—-8.23),在艾滋病毒母婴传播的信息(优势比= 3.65,95% CI: 1.49—-8.95),不使用避孕套在性交过程中(优势比= 4.86,95% CI: 2.46—-9.62),,知识对表面(优势比= 2.38,95% CI: 1.24—-4.58)和表面的态度(优势比= 6.41,95% CI: 3.16—-13.0)是独立的决定因素表面利用率在HIV阳性的女性。结论和建议:经卫生保健提供者咨询、没有未来生育意图和CD4细胞计数低于500细胞/立方毫米的妇女被发现是艾滋病毒阳性育龄妇女使用长效避孕方法的决定因素。此外,我们的研究支持世卫组织改善计划生育与艾滋病毒/艾滋病政策、规划和服务之间联系的战略概念。建议卫生保健提供者在计划生育咨询和提供服务时应将这些因素作为基线。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信